No Data
No Data
Leerink Partners Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $82
Earnings Call Summary | ANI Pharmaceuticals(ANIP.US) Q4 2024 Earnings Conference
ANI Pharmaceuticals Up Over 12%, on Pace for Largest Percent Increase Since November 2021 -- Data Talk
Why Is ANI Pharmaceuticals (ANIP) Stock Soaring Today
ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast
Sector Update: Health Care Stocks Steady Pre-Bell Friday
Unlock the Full List